Neuronal plasticity: a link between stress and mood disorders

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• Stress is a significant risk factor for mood disorders, but its precise mechanisms are not fully understood.
• While neurotransmitter imbalances (norepinephrine, serotonin) are implicated, reduced neuronal plasticity is increasingly recognized in depression.
• Neurotrophic factors, like brain-derived neurotrophic factor (BDNF), play a crucial role in neuronal health and function.

Purpose of the Study:

• To review the evidence linking stress, neuronal plasticity, and mood disorders.
• To highlight the role of neurotrophic factors, particularly BDNF, in the pathophysiology of depression.
• To discuss the impact of stress across the lifespan on neuroplasticity and potential therapeutic interventions.

Main Methods:

• Review of existing scientific literature and studies on stress, mood disorders, and neurobiology.
• Analysis of research on neurotrophin expression (specifically BDNF) in depressed individuals and animal models.
• Examination of the effects of chronic and acute stress on neuroplasticity and BDNF levels.

Main Results:

• Stress exposure, at various life stages, leads to decreased neuronal plasticity and reduced BDNF expression.
• These neuroplasticity deficits are anatomically specific and may involve epigenetic modifications.
• Chronic antidepressant treatment can normalize BDNF expression and synaptic localization, counteracting stress-induced deficits.

Conclusions:

• Neuronal plasticity and BDNF are central to understanding how stress affects brain function and contributes to psychopathology.
• Impaired neuroplasticity, sustained by stress, is a key feature of mood disorders.
• Effective treatments must address and normalize defective neuroplasticity mechanisms, beyond neurotransmitter regulation.